Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for symptomatic dysuria in women with multiple sclerosis
2024-516880-10-00Phase 2Completed
- Sponsor
- CHU Nîmes
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tamsulosin in multiple sclerosis (MS) and Micturition disorder (2 arms), sponsored by CHU Nîmes. Primary endpoint: Change in IPSS score. Started Jun 2022; status: completed.
02
Drugs
tamsulosin
03
Conditions
multiple sclerosis (MS)Micturition disorder
Beyond the preview
Go deeper on 2024-516880-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516880-10-00.